Provided by Tiger Trade Technology Pte. Ltd.

ProQR Therapeutics NV

1.86
-0.0800-4.12%
Post-market: 1.860.00000.00%16:10 EDT
Volume:579.21K
Turnover:1.09M
Market Cap:262.48M
PE:-4.06
High:1.98
Open:1.97
Low:1.85
Close:1.94
52wk High:3.10
52wk Low:1.33
Shares:141.12M
Float Shares:101.18M
Volume Ratio:0.98
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4578
EPS(LYR):-0.4702
ROE:-57.40%
ROA:-19.76%
PB:2.85
PE(LYR):-3.96

Loading ...

ProQR Q1 FY26 net loss widens to €13.38 million; revenue drops to €2.03 million

Reuters
·
May 12

BRIEF-ProQR Therapeutics Q1 EPS EUR -0.13

Reuters
·
May 12

ProQR Therapeutics Q1 Revenue EUR 2.033 Million VS. Ibes Estimate EUR 5.25 Million

THOMSON REUTERS
·
May 12

ProQR Therapeutics Q1 Net Income EUR -13.383 Million

THOMSON REUTERS
·
May 12

ProQR Therapeutics Q1 Basic EPS EUR -0.13

THOMSON REUTERS
·
May 12

ProQR to present Axiomer RNA editing data at upcoming scientific conferences

Reuters
·
May 11

ProQR Therapeutics NV expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 04

ProQR Therapeutics announces annual shareholder meeting

Reuters
·
May 04

ProQR Announces Nomination of DR. Lykke Hinsch Gylvin to Its Board of Directors

THOMSON REUTERS
·
Apr 30

ProQR spotlights AX-0810 milestones at investor and analyst event

Reuters
·
Apr 09

BRIEF-Proqr Announces Partnership With Ginkgo Bioworks And Formation Of Ai Advisory Board

Reuters
·
Apr 08

ProQR partners with Ginkgo Bioworks to scale AI-enabled RNA editing discovery

Reuters
·
Apr 08

ProQR Announces Partnership With Ginkgo Bioworks and Formation of AI Advisory Board

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics Nv - Expects First AI-Discovered Development Candidate to Enter Clinic in 2026

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics Nv - Ginkgo Bioworks Makes Strategic Equity Investment in ProQR

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics to host virtual investor and analyst event; pipeline spotlight to include AX-0810 indication update

Reuters
·
Mar 25

ProQR Therapeutics’ Chief Scientific Officer Gerardus Johannes Platenburg files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics NV Director Domenico Valerio Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

ProQR Therapeutics NV CFO Dennis Hom files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics director Alison Frances Lawton files Form 3 initial beneficial ownership statement

Reuters
·
Mar 19